NPPB block of the intermediate-conductance Ca2+-activated K+ channel

Eur J Pharmacol. 2004 Aug 16;497(1):1-6. doi: 10.1016/j.ejphar.2004.06.034.

Abstract

We have shown that the Cl(-) channel blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) also blocks the intermediate-conductance Ca(2+)-activated K(+) (IK(Ca)) current in human leukemic HL-60 and glioblastoma GL-15 cell lines. The macroscopic IK(Ca) current was activated by ionomycin plus 1-EBIO, and identified as intermediate conductance by being fully blocked by charybdotoxin, clotrimazole, nitrendipine (L-type Ca(2+) channel blocker), and NS1619 (BK(Ca) channel opener), but not by D-tubocurarine or TEA. The IK(Ca) current was blocked by NPPB in a reversible dose-dependent manner, with an IC(50) of 39 microM in HL-60 and 125 microM in GL-15 cells. The block of the IK(Ca) current was also recorded at the single channel level in excised inside-out patches. As expected, NPPB also blocked the volume-activated Cl(-) current expressed by GL-15 cells, with an IC(50) of 44 microM. The functional implications of IK(Ca) current block by NPPB are discussed.

Publication types

  • Comparative Study

MeSH terms

  • Cell Line, Tumor
  • Chloride Channels / antagonists & inhibitors*
  • Chloride Channels / physiology
  • Dose-Response Relationship, Drug
  • Humans
  • Nitrobenzoates / administration & dosage
  • Nitrobenzoates / pharmacology*
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / administration & dosage
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels, Calcium-Activated / drug effects*
  • Potassium Channels, Calcium-Activated / physiology

Substances

  • Chloride Channels
  • Nitrobenzoates
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • 5-nitro-2-(3-phenylpropylamino)benzoic acid